Patent Settlements Stir Supreme Court Interest During Slow Term For Pharma Cases
This article was originally published in The Tan Sheet
Executive Summary
High court seeks Solicitor General's view on whether patent settlements blocking authorized generics are anticompetitive; court denies GSK petition challenging payer claims in Avandia litigation.